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PREHOSPITAL CONTINUOUS POSITIVE AIRWAY PRESSURE FOR ACUTE 





Acute respiratory failure (ARF) is a common problem presenting to emergency medical 
services and is associated with significant morbidity, mortality and health care costs. 
Continuous positive airway pressure (CPAP) is an integral part of the hospital treatment of 
acute respiratory failure, predominantly due to congestive heart failure. Intuitively, better 
patient outcomes may be achieved when CPAP is applied early in the pre-hospital setting but 
there are few outcome studies to validate its use in this setting. 
AIM 
This systematic review and meta-analysis aimed to examine the effectiveness CPAP in the 
pre-hospital setting for patients with ARF.  
METHODS 
A literature review of bibliographic databases and secondary sources was conducted and 
potential papers assessed by two independent reviewers. Included studies were those that 
compared CPAP therapy (and usual care) to no CPAP for ARF in the prehospital setting. 
Studies of other methods of non-invasive ventilation were not included. Methodological 
quality was assessed using guidelines from the Cochrane Collaboration. Outcomes included 
the number of intubations, mortality, physiological parameters and dyspnoea score. Forrest 
plots were constructed to estimate the pooled effect of CPAP on outcomes. 
RESULTS 
Five studies (1,002 patients) met the selection criteria – three randomised control trials 
(RCTs), a non-randomised comparative study and a retrospective comparative study using 
chart review. Forty-seven percent of patients were allocated to the CPAP group. Baseline 
characteristics were similar between groups. The pooled estimates demonstrated significantly 
fewer intubations (OR 0.31, 95% CI 0.19-0.51) and lower mortality (OR 0.41, 95% CI 0.19-
0.87) in the CPAP group. 
CONCLUSION 
The studies included in this review showed a reduction in the number of intubations and 
mortality in patients with ARF who received CPAP in the pre-hospital setting. The results 
may not be applicable to other health care contexts because of the inherent differences in the 
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organisation and staffing of the EMS. Information from large RCTs on the efficacy of CPAP 
initiated early in the pre-hospital setting is critical to establishing the evidence base 





Acute respiratory failure (ARF), defined by the presence of hyoxaemia or hypercapnia, is a 
common problem presenting to emergency medical services (EMS).  ARF is most commonly 
caused by diseases of the cardiac (e.g. left ventricular failure, pulmonary embolus) or 
respiratory system (e.g. chronic obstructive pulmonary disease [COPD], asthma, pneumonia).  
Identifying the precise cause of ARF in the pre-hospital setting is challenging: the time 
window for assessment is limited, it is not possible to obtain a chest x-ray or other diagnostic 
imaging and environmental considerations (avoiding exposing the patient, noise) make 
clinical examination difficult.  
 
The most common cause of acute respiratory failure is left ventricular failure causing acute 
cardiogenic pulmonary oedema (ACPO), a potentially life-threatening medical emergency 
that is associated with significant morbidity, mortality and health care costs.1 Other causes of 
acute pulmonary oedema (APO) are cardiac (includes myocardial ischaemia, hypertension, 
arrhythmias) and non-cardiac (includes drugs, poisoning). Non-cardiogenic pulmonary 
oedema is often evident from the patient history surrounding the acute event and is due 
primarily to a disruption in the alveolar–capillary membrane from an insult (e.g. sepsis, 
trauma, drugs).2 While they have distinct causes, acute cardiogenic and non-cardiogenic 
pulmonary oedema have similar clinical manifestations.3 Furthermore, patients with COPD 
often present with ACPO due to coexisting cardiac disease and it may be difficult to 
differentiate between them2 especially in the pre-hospital emergency setting. However, it is 
important to understand the cause of APO because it has important treatment implications. 
Patients with cardiogenic pulmonary oedema typically are treated with preload and afterload 
reduction using drugs such as nitrates. Patients with non-cardiogenic pulmonary oedema 
require support of oxygenation and ventilation and treatment of the underlying cause.3 
 
Continuous positive airway pressure (CPAP) is an integral part of the hospital treatment of 
APO and provides beneficial effects on respiratory and cardiac function.4-6 This non-invasive 
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medical therapy maintains positive airway pressure during spontaneous ventilation 
throughout the whole respiratory cycle, reducing dyspnoea and the work of breathing. Several 
reports that describe CPAP,7-12 applied by face or nasal mask, improves gas exchange, 
reduces the need for endotracheal intubation (and the potential complications of mechanical 
ventilation),13 and decrease length of stay (LOS) in the intensive care unit (ICU), coronary 
care, emergency department (ED) and hospital. CPAP is most beneficial in patients with 
APCO, but patients with other causes of acute respiratory failure, e.g. acute exacerbations of 
COPD also benefit.14 Intuitively, better patient outcomes may be achieved when CPAP is 
applied early in the pre-hospital setting, but outcome studies in the pre-hospital setting are 
required to validate its use.14,15 This information is critical to establishing the evidence base 






We conducted a systematic review and meta-analysis of the evidence of the clinical efficacy 
of pre-hospital administration of CPAP in patients with acute respiratory failure.  
 
Search strategy 
To identify studies eligible for review, computerized searches of bibliographic databases 
were performed (author TW): MEDLINE (1980–2012), EMBASE (1980–2012), CINAHL 
(1982–2012) and the Cochrane Library (2004—2012). Terms were mapped to the appropriate 
MeSH/EMTREE subject headings and “exploded”: (1) [“acute pulmonary oedema” OR 
“pulmonary oedema” OR “acute heart failure” OR ‘acute respiratory failure”] AND 
[“continuous positive airway pressure”] (2) [“continuous positive airway pressure”] AND 
[“ambulance” OR “emergency medical services” OR “pre-hospital care” OR mobile health 
units ”OR “paramedic”]. Reference lists of relevant review articles and journals were hand-
searched for relevant papers. 
 
Potential studies were limited to studies conducted within the prehospital setting that 
compared patients with acute respiratory failure who received CPAP and usual care (CPAP 
group) to those receiving usual care (non-CPAP group) transported to hospital by ambulance. 
We did not include studies of neonates. Studies that did not specifically compare patients 
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with acute respiratory failure,16,17,18 ,19 did not compare the CPAP group with a non-CPAP 
group,20,21 or those that included patients who received bilevel positive airway/pressure 
support ventilation22-27 were excluded. Outcomes included changes in physiological values 
(respiratory rate, oxygen saturation [SpO2 or SaO2], intubation, mortality and intensive care 
unit (ICU) or hospital length of stay (LOS). Papers were included if they were published in 
English. Articles had to be published in peer-reviewed journals but those published only in 
abstract form were excluded. No time limits on journal publication date were set. If reports 




Studies identified during the literature search were assessed for relevance to the review based 
on the information contained in the title, abstract and subject descriptor/MeSH heading 
(authors TW and JF). Full text articles were obtained if, after reviewing the abstract, the study 
was considered relevant or if the title and abstract were inconclusive. All citations selected by 
either author for abstract review were eligible for selection, and any subsequent disagreement 
regarding eligibility resolved by consensus. 
 
Data extraction 
Data were extracted by two investigators (authors TW and JF) from studies that met the 
inclusion criteria. We did not get primary data verified from investigators. The data were 
collected on a form that included study design, patient characteristics (e.g. age, sex, 
diagnosis), treatments received, emergency medical services, reported outcomes (mortality, 





Using guidelines from Ryan et al.28 and Higgins and Green,29 study quality was assessed for 
risk of bias, adherence to the intention-to-treat principle, completeness to follow-up, 
heterogeneity, and loss to follow-up. In addition, for non-randomised studies similarity of 
baseline characteristics was examined. If groups were not reasonably equivalent and this was 




Assessment of risk of bias in included studies 
Allocation concealment was rated as (a) adequate if the randomisation method would not 
enable the investigator or participant to know or influence allocation intervention group 
before an eligible participant was entered in the study; (b) unclear if randomisation stated but 
no information on the method used is available; (c) inadequate if the method of 
randomisation used indicated that investigators or participants could influence the 
intervention group; and (d) randomisation not done.28 
 
Adherence to the intention-to-treat principle 
If an intention-to-treat analysis was reported to have been undertaken by the investigators and 
this was confirmed on study assessment then adherence to the intention-to-treat principle was 
assumed.28 If not reported and lack of intention-to-treat analysis was confirmed on study 
assessment, e.g. patients who were randomised were not included in the analysis because they 
did not receive the study intervention, they withdrew from the study or were not included 
because of protocol violation, it was assumed that there was no adherence to the intention-to-
treat principle. 
 
Assessment of heterogeneity 
Statistical heterogeneity was assessed using the Higgins I2 test,30 which estimates the 
variability due to heterogeneity rather than chance alone. I2 values less than 25% are 




A priori sensitivity analyses were proposed to explore the impact of excluding studies that 
met the inclusion criteria but not the assessment of study quality on outcomes.  
 
Publication bias 
The intubation rate from the studies were used to construct a funnel plot, to investigate the 
likelihood of overt publication bias.29 The vertical axis indicates the standard error of the log 
odds ratio and the horizontal axis the logit odds ratio.31 In the absence of bias the plot 
resembles a symmetric inverted funnel, but if there is bias it appearsasymmetric with a gap in 





Narrative and tabular summaries of study characteristics, methods and results are presented, 
guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) statement.32 Summary estimates of treatment effect with their associated 95% 
confidence intervals (CI) are reported. A protocol was not registered for the systematic 
review. We pooled dichotomous outcomes (using odds ratio [OR]) using random effects 
models. Data were analysed using Review Manager (RevMan) version 5.1 software (The 
Cochrane Collaboration, Oxford, UK) and STATA (Release 12: StataCorp LP, College 




We identified 160 reports of studies. After title and abstract assessment, 95 reports were 
excluded because it was evident that the publications were not comparative studies or did not 
include either the target population or the intervention of interest. We retrieved 65 full text 
reports for further evaluation, and seven were finally included.  
INSERT FIGURE 1 HERE 
 
Study characteristics 
There were 14 studies of CPAP used in the pre-hospital setting. 14,16-19,22,33-39 We did not 
include six studies of prehospital CPAP16-19,22,33 because they did not have a comparison 
group. The Plaisance et al.20 RCT was excluded because it did not compare the CPAP group 
to a non-CPAP group but instead compared ‘early’ CPAP to ‘late’ CPAP. Seven studies14,34-39 
compared the effect of prehospital CPAP to no CPAP - three randomised controlled trials 
(RCTs)14,35,36, a non-randomised concurrent comparative study,38 two before and after 
studies,37,39 and a retrospective review of prehospital charts.34 Only one of the studies 
involved multiple centers.35 
 
The studies included in this review (Table 1) were conducted in different healthcare contexts: 
one was conducted in Canada,14 two in France35,36 and four in the United States of America 
(USA).34,37-39 In the mobile ICUs in France, physicians are part of the EMS team, but are not 
routinely used in the USA and Canada. Differences also exist within the same context. For 
example, Hubble et al.38 used two neighbouring EMS counties with different levels of 
services: one county for the control group and the other for the intervention group. 
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INSERT TABLE 1 HERE 
 
Study quality 
None of the studies were blinded, as shown in Table 1, but it would be technically and 
operationally difficult to blind the paramedics. The three RCTs14,35,36 were considered low 
risk for bias. Hubble et al.38 had a moderate risk of bias because it was a well conducted, non-
randomised comparative clinical study. Two studies had a high risk of bias.34,37,39 Hastings et 
al.37 described a decrease in the number of intubations from 20% to 1% but did not describe 
the number of patients or the characteristics of the comparator group and was excluded from 
the outcome analyses.37 Warner et al.39 conducted a before and after study but did not 
describe the characteristics of the groups and was also excluded from further analyses. 
Publication bias is shown in Figure 2. 
INSERT TABLE 2 HERE 
INSERT FIGURE 2 HERE. 
 
Study participants 
There were 1002 patients enrolled across five studies,14,34-36,38 of whom 471 (47%) were 
allocated to the CPAP group. The number of patients recruited in each study ranged from 71 
to 387. The average age of participants was 76 years non-CPAP group versus 75 years in the 
CPAP group (when reported) and the proportion of males was similar (50% non-CPAP group 
versus 47% CPAP group, p=0.25). Three studies reported outcomes for patients with severe 
CHF34 or ACPO.35,36  A further study examined outcomes for patients with APO but the 
majority of patients (76%) were diagnosed in ED with cardiogenic pulmonary oedema.38 
Thompson et al.14 recruited patients with severe respiratory distress, predominantly CHF, 
COPD or asthma. 
 
Standard therapy included use of oxygen, nitrates and diuretics (furosemide) although the 
mode of delivery (oral versus parenteral) varied within and between EMS. The therapies for 
APO were provided at the discretion of the treating paramedics,34,38 or protocol-driven35,36 
depending on the EMS but some adjunctive therapies were mandatory.35 Delivery of CPAP 
was by facemask.14,35,36,38 CPAP was generated by oxygen-driven Venturi devices which 
deliver high gas flow with adjustable fractional inspired oxygen (FiO2) in three studies
35,36,38 
or fixed-flow generator with pre-set FiO2 and no allowance for titration of FiO2.
34 Four 
studies set the pressure for CPAP at 10 cm14,34,36,38 and Ducros et al.35 initially set the 
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pressure for CPAP to 7.5 cm H2O for 15 minutes and increased it to 10 cm H2O if tolerated. 
Only one study35 set a target SpO2. 
 
Outcomes 
Outcomes from the five studies included in this systematic review are shown in Table 3. The 
requirement for intubation overall was reported as a primary or secondary outcome in five 
studies14,34,36,38,39 or included as part of a composite outcome.35 Different time points were 
used to assess intubation rates. The use of CPAP was associated with a 69% reduction in the 
number of intubations overall, as shown in Figure 2 (OR 0.31, 95%CI 0.19-0.51). Similar 
results were found when the two French studies were excluded (OR 0.30, 95% CI 0.17-
0.53)35,36 but not significant for pre-hospital intubation only (OR 0.43, 95% CI 0.18-
1.02).14,34,36  
INSERT TABLE 3 HERE 
INSERT FIGURE 3 
 
Composite endpoints were used as the primary outcome in two studies.35,36 Assessed within 
48 hours after inclusion, Ducros et al.35 combined death, necessity of intubation, persistence 
of either all inclusion criteria or circulatory failure at 2 hours or reappearance after 2 hours. 
There was no difference in the composite outcome between the CPAP and usual care group. 
A secondary outcome was the composite primary endpoint without the intubation criteria. 
Frontin et al.36 used treatment success, defined as the respiratory rate less than 25 breaths per 
minute and SpO2 greater than 90% at the end of the 1-hour study. 
 
Mortality was measured at different time points (Figure 3). Pre-hospital patient mortality,34 
in-hospital mortality,35,38 and 30-day mortality36 were reported. Hubble et al.38 had the 
highest decrease in mortality, from 23% in the non-CPAP group to 5.5% in the CPAP group. 
Pooled results demonstrated an overall 59% decrease in mortality, OR 0.41, 95% CI 0.19-
0.87 (Figure 4). 
INSERT FIGURE 4 
 
The sensitivity analysis could not be performed for the studies excluded because of quality. 
There was no denominator for the non-CPAP group in one study37 and there were no 




Changes in physiological values - respiratory rate, heart rate and blood pressure were also 
assessed,34-36,38 as shown in Table 3. Most studies reported physiological outcomes at 1 hour. 
Others reported the final set of physiological outcomes used recorded just before ED 
arrival.34 One study reported physiological values recorded at several intervals up to 6-
hours.35 When data points were not present in the final set, the immediately preceding 
complete set was used.34 Improvements in the changes of physiological values were 
inconsistent and had high heterogeneity, as shown in Table 4 
 
Length of stay in ICU35,36 and hospital LOS36,38 showed no difference (Table 4). The 
requirement for inotropic support36 35 was assessed in two studies and in one study BNP 
levels during the first 24 hours, peak troponin I level; cumulated doses of nitrates and 
diuretics were reported.35 Changes in BNP levels in the first 24 hours were similar in both 
groups.35 
 
Dyspnoea score was reported in two studies.36,38 Patients self-evaluated their perceived 
breathlessness using a scale ranging from 0 (no breathlessness) to 10 (maximal 
breathlessness). The reduction in dyspnoea score was significant in one study.38 
 
Adverse events/complications such as mask intolerance, barotrauma, vomiting or gastric 
distension were also assessed. Two patients experienced vomiting in the CPAP group and 
three in the usual care group but adverse events such as mask intolerance, barotrauma, or 







This systematic review found seven studies that compared CPAP to non-CPAP treatment for 
patients with respiratory distress in the pre-hospital setting. Two studies37,39 did not compare 
baseline characteristics and were excluded from analyses of outcomes. Pooling the results of 
the five eligible studies, we demonstrated fewer intubations and decreased mortality when 
CPAP was used in the prehospital setting. There was wide variation in the intubation and 
mortality rates, from 0% to 50% for intubation and 0% to 35% for mortality in the non-CPAP 
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groups. The variability may be related to the differences between health care systems. For 
example, the French EMS has mobile ICUs staffed by a physician (who is usually an 
experienced emergency physician or anaesthetist), a nurse and an emergency medical 
technician.36 In comparison, EMS systems in North America, United Kingdom and Australia 
ambulances are often staffed by paramedics who do not have the same clinical resources and 
expertise as mobile ICUs. Furthermore, Australian studies of critical illness have shown 
lower baseline and treatment mortality compared to international studies,40 and hence such 
dramatic improvements with CPAP may not be replicated in other health care contexts. Also, 
the exclusion of patients with “do not resuscitate” orders may influence outcomes. Patient 
outcomes that were not statistically significant in the two French RCTs in this systematic 
review and meta-analysis were likely due to the studies not being adequately powered for 
these outcomes.  
 
The cause of respiratory failure may have influenced intubation and mortality rates but this 
was not examined in four studies. Logistic regression modelling of intubation outcomes  by 
Thompson et al14 found, after adjustment for allocation to the CPAP group, female sex, age 
out-of-hospital, peripheral oxygen saturation, out-of-hospital respiratory rate, ED diagnosis of 
pneumonia and ED diagnosis of acute coronary syndrome that CPAP independently reduced 
the number of intubations (adjusted OR 0.16; 95% CI 0.04 to 0.7). Studies of the hospital 
administration CPAP9-11,41-57 initially targeted APO, particularly ACPO and similarly studies 
of prehospital CPAP.17-20,25,34-36 Intubation for acute cardiogenic pulmonary oedema ranged 
from 5% to 6% for non-CPAP compared to 3 to 5% for the CPAP group and mortality varied 
for the non-CPAP group from 0% to 11% and CPAP group 0% to 5%.34-36 Paramedic 
assessment of the medical history to identify patients with acute congestive heart failure 
among critically ill patients struggling to breathe in the prehospital-setting can be difficult. 
Correct identification of patients who meet eligibility criteria or whose treatment decisions 
depend on these data is important. Hubble and colleague’s study 38 of APO showed that 24% 
of patients did not have APO and for those who did, the intubation rate was 28% and 
mortality 25%. With the exception of studies of patients treated by mobile ICU17 feasibility 
studies of CPAP for patients with acute cardiogenic pulmonary oedema report 16-32% of 
cases were misdiagnosed.16 18 Other diseases such as chronic obstructive pulmonary disease 
or asthma have also been treated by CPAP.23,58,59 Thompson et al.14 recruited patients with 
acute respiratory failure and reported an intubation rate of 50% and in-hospital mortality of 
35% in the non-CPAP group and 20% and 14% respectively in the CPAP group. Including all 
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cases of severe acute respiratory failure in this systematic review increased the 
generalisability of the results, but there is a large variation in the number of intubations and 
mortality. Further research is required. 
 
Mortality as an end point is objective and its clinical relevance is important but requires large 
sample size for valid assessment in the pre-hospital setting. Recruiting patients for these 
studies may be difficult. For example, Ducros et al.35 recruited only half of their estimated 
sample and had to terminate their study early because data collection time exceeded planned 
duration due to low patient recruitment. Treatments received and other factors after the 
patient has been transported to the ED may influence in-hospital or 30-day mortality greater 
than pre-hospital care. The number of intubations is also an important outcome because of the 
associated risks with intubation and higher costs associated with the ICU admission and 
longer hospital stay. The proportion of patients intubated and dying in the field is 
comparatively low so large sample sizes would need to be recruited to ensure the study has 
adequate power to detect significant differences. Surrogate measures such as physiological 
values are a substitute for a clinically meaningful end point that is a direct measure of how a 
patient feels, functions, or survives60 are used to assess the effect of the therapy. It is 
unknown if improvements in physiological values are associated with improved mortality and 
other patient-centred outcomes. Improvements in physiological values were reported but the 
results were inconsistent. 
 
Dyspnoea, described as sensations of work or effort, tightness, or air hunger that is 
unsatisfied on inspiration, is a common and important symptom reported by patients with 
acute respiratory failure.61 To manage patients with symptoms of dyspnoea, dyspnoea should 
be assessed using appropriate measures. Two studies assessed dyspnoea in this systematic 
review but few reports describe dyspnoea scores in studies of pre-hospital CPAP.20,36,38 
Visual analogue scales62-64 and the Borg dyspnoea scale65,66 are sensory–perceptual measures 
that include ratings of intensity or sensory quality. They are used in the pre-hospital setting 
but there are no validated instruments for dyspnoea assessment that have accuracy, reliability, 
reproducibility between observers, and are sensitive to important changes in dyspnoea.67 
Further, assessment of dyspnoea is challenged because dyspnoea scores tend to improve 




Recent guidelines 68recommend CPAP in the prehospital setting administered by advanced-
level EMS providers in both urban and rural settings.59 The safety of administering CPAP has 
been reported in several small observational European and North American observational 
studies,16-18,34,37 Early CPAP, when compared to later CPAP, has been shown to have 
improved outcomes.20 Nevertheless, consideration must be given to the feasibility to 
delivering CPAP in the pre-hospital setting. Devices to deliver CPAP are often driven by 
oxygen and large volumes may be required. Ambulances must have the capacity to carry 
sufficient amounts of oxygen to ensure availability of oxygen from any distance to definitive 
care that is required. Furthermore its potential benefit must be weighed against possible 
transport delays for critically ill patients. 
 
Limitations 
Five studies were reviewed in this systematic review and meta-analysis. We did not include 
non-English language papers so we have may have missed some relevant papers. We may 
have also missed some relevant English-language papers but we conducted an extensive 
systematic, literature review to minimise this. 
 
We included non-randomised trials and observation studies provided that they compared the 
baseline characteristics. Non-randomised studies have inherent biases due to the non-random 
allocation of the intervention. The risk of potential selection bias from the study conducted by 
Dib et al.34 was high, e.g. from non-randomization of patients, and patients and paramedics 
not being blinded to treatment. The investigators also acknowledge that the reason that 
patients did not receive CPAP was largely because of paramedic inexperience in 
administering the treatment.34 The method of data collection also increased the risk for bias. 
The identification of acute congestive heart failure was made by two physicians who 
accessed patients’ history, treatment and outcomes from a retrospective chart review. 
Paramedics in the field usually do not have access to this information. Inspired oxygen 
concentration per CPAP level should be titrated to achieve a target SpO2 Hyperoxia is 
potentially linked to worse outcomes (e.g. myocardial infarction, COPD).33 Titrating oxygen 
and CPAP levels to achieve a target SpO2 should be evaluated in future trials. The use of 
concurrent controls and adjustment for potential confounding factors in regression models38 
reduces the potential risk for bias. It is likely that some potential confounders are unknown. 
For example, there is no way to know that more than one episode for a patient has been 
included in the study unless declared by the authors and this information may not be reported. 
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Also, not knowing whether intubation has been withheld could be significant to the 
interpretation of the findings. We assessed studies for methodological quality, based on the 
evaluation system recommended by Ryan et al.28 and the Cochrane Collaboration.29 All of the 
papers were from developed countries and it is unknown if the results from this systematic 
and meta-analysis would be different if studies had been conducted in other settings. 
 
CONCLUSION 
The studies included in this review showed a reduction in the number of intubations and 
mortality in patients with acute respiratory failure who received CPAP in the pre-hospital 
setting. The results may not be applicable to other health care contexts because of the 
inherent differences in the organisation and staffing of the EMS. Limitations of this 
systematic review and meta-analysis are the small number of studies and even fewer RCTs. 
Information from large RCTs on the efficacy of CPAP initiated early in the pre-hospital 
setting is critical to establishing the evidence base underpinning this therapy prior to 
ambulance services incorporating CPAP as routine clinical practice.  
 
Several small studies have shown a reduction in the rate of intubations and mortality in 
patients administered CPAP for acute respiratory failure in the pre-hospital setting. The 
results may not be applicable to other health care contexts because of the inherent differences 
in the organisation and staffing of the EMS. Information on the efficacy of CPAP initiated 
early in the pre-hospital setting is critical to establishing the evidence base underpinning this 
therapy prior to ambulance services incorporating CPAP as routine clinical practice. 
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Figure 1. Flow diagram of study selection 
Figure 2. Publication bias 
Figure 3. Forrest plot showing the pooled estimate of effect of CPAP on the risk of intubation 
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Table 1. Studies that met the inclusion criteria for this systematic review before assessment of 
the study quality 
Study Emergency Medical 
Service 
Design Selection criteria Number of 
patients 
Dib et al. (2012)34  EMS, New Jersey 
Paramedics 
Two-tier EMS system: 
BLS and ALS 
ALS only to those 
calls requiring 
possible ALS care 
and intervention, e.g. 
shortness of breath 
Retrospective review 
prehospital charts  
January 2005 –December 
2006 
Ethic Committee approval 
Patients treated for severe acute CHF if 
 Respiratory rate > 25 breaths per 
minute 
 Laboured and shallow breathing 
 Bilateral rales 
 History of CHF 
 Intact mental status 
387 patients: 
CPAP = 149  
Non-CPAP = 238 





Multicentre RCT  
Control group - standard 
treatment 
Experimental group - 
standard treatment plus 
CPAP 
Ethic Committee approval 
Included patients with cardiogenic 
pulmonary oedema if 
 Orthopnoea 
 Respiratory rate > 25 breaths per 
minute 
 SpO2 less than 90% in room air  
 Diffuse crackles 
Excluded  
 History of COPD, asthma, severe 
stenotic valve disease 
 Immediate indication for intubation 
(severe impairment of 
consciousness, bradypnoea) 
 Cardiovascular collapse or suspicion 
of STEMI 
207 patients: 
CPAP = 107  







estimated at 200 




due to low patient 
recruitment, trial 
stopped after 207 
patients  
Frontin et al. 
(2011)36 
Mobile ICU (Physician 
staffed) 
Prehospital 
emergency service of 
University Hospital in 
metropolitan area 
Toulouse, France 
Single centre RCT 
September 2006 and March 
2008 
Ethic Committee approval 
Out-of-hospital patients in severe 
acute cardiogenic pulmonary oedema 
Included 
 Age >= 18 years 
 Respiratory rate > 25 bpm 
 Orthopnoea 
 Diffuse crackles without evidence 
of pulmonary aspiration or 
infection 
 SpO2 <90% 
Excluded 
 cardiovascular collapse 
 Impaired consciousness  
 AMI 
 Immediate need for intubation 
 History gastric surgery (<8 days) 
 Vomiting 
124 patients: 
CPAP = 60  
Non-CPAP = 62 






in rate of previous 
ACPE between 





States of America 
Before and after 6-month 
study 
Before: Retrospective chart 
review of patients matching 
study inclusion criteria pre 
introduction of nasal CPAP 
After Data collection 
Ethics approval not stated 
Severe respiratory distress with APO 
secondary to congestive heart failure 
and renal failure. 





 Verbal impairment 
 SpO2 <90% 
CPAP group=32 
Age ranged from 
50 to 90 years 
Comparator 







Hubble et al. 
(2006)38 
Two EMS systems 
Two-tiered EMS -  
BLS team dispatched 
to all emergency 
calls, and ALS 
Paramedics 
dispatched only to 
calls requiring 
possible ALS care 
and intervention e.g. 
chest pain or 
shortness of breath  




1/7/2004 – 30/6/2005 
Ethic Committee approval 
All consecutive patients presenting with 
APO as identified by paramedics 
215 patients: 
CPAP =120 













to academic tertiary 
care center) or 
General Hospital 
Paramedics 
Public utility model in 
which the government 
owns all ambulances 







Canada, July 2002 –
December 2006 
Paramedics contacted 
dispatcher by radio who 
randomly assigned patient to 
usual care or CPAP 
Randomization sequence 
generated from random-
numbers table. Customized 
tool permitted sequential 
exposure to allocation 
sequence via numbered, 
opaque stickers 
Ethic Committee approval 
Acute respiratory failure - severest 
subset of the out-of-hospital “shortness 
of breath” 
Included 
 Severe respiratory distress with 
failing respiratory efforts (paramedic 
judgment) 
 Accessory muscle use 
 Respiration rate >25 breaths/min 
 Hypoxia 
Excluded 
 Respiratory arrest or near arrest 
(paramedic judgment) 
 Respiration rate <8 breaths/min 
 Periods of apnoea 
CPAP = 35 
Non-CPAP = 34 













Warner (2010)39 Paramedics Alabama, 
US 





8-month, before and after 
observational, non-blinded 
study 
Before November 2007- 
February 2008 
After March to June 2008 
Ethics approval not stated 
Respiratory distress (dyspnoea, 
respiratory rate >25 bpm, and/or 
retractions or accessory muscle use, 
arterial hypoxemia  
SpO2 < 95% in spite of administration of 
supplemental O2) PLUS 
 mental alertness (GCS>10) 
 ability to maintain open airway 
 SBP >90 mmHg 
Excluded  
 ventilatory arrest 
 suspected pneumothorax / 
penetrating chest trauma 
 tracheostomy 
 agonal ventilations 
 unconsciousness 
 persistent nausea and vomiting 
 facial trauma or malformation  
 active upper gastrointestinal bleeding 
or recent gastric surgery (<2 weeks) 







No description of 
patient 
characteristics 
ACPE Acute Cardiogenic Pulmonary Oedema   ALS Advanced Life Support 
ASPE Acute Severe Pulmonary Oedema  BLS Basic Life Support 
bpm Breaths per minute    CHF Chronic Heart Failure 
CPAP Continuous Positive Airway Pressure   EMS Emergency Medical Services 
ETI EndoTracheal Intubation   GCS Glasgow Coma Score 
ICU Intensive Care Unit    RCT Randomised Controlled Trial 






Table 2 Study quality and potential risk of bias 


























Study blinded No No No No No No No 
Adherence to  intention-to-
treat principle 







Yes No No No 







Nil Not stated One Not stated 
Informed consent obtained Yes Yes Yes Waiver of 
consent 
No Yes No 
Groups comparable at 
baseline  
Yes Yes Yes Yes Unknown Yes Unknown 
* adequate = randomisation method would not enable the investigator or participant to know or influence allocation intervention group 








Table 3. Summary of results from comparative studies  
Study Outcome Non-CPAP CPAP ‘p’ value / OR & CI 
Dib et al. (2011)34 Pre-hospital time* (minutes) 31 30 >0.01 
Non-CPAP = 238 Physiological changes    
CPAP = 149  Respiratory rate decrease  4.09 bpm 5.63 bpm <0.01 
  SaO2 increased 5% 9% <0.01 
  SBP reduction 19.9 mm Hg 27.1 mm Hg <0.01 
  DBP reduction 7.4 mm Hg 14.1 mm Hg 0.01 
  Heart rate reduction 9.6 beats/min 17.2 beats/min < 0.01 
 Pre-hospital intubation n (%) 11 (5.5%) 4 (2.6%) < 0.01 
 Mortality Nil Nil  
Ducros et al. (2011)35 Median time between recruitment 
and hospital admission (IQR)  
82 min (69, 95) 88 min (75, 104)  
Non-CPAP =100 
CPAP = 107  
Physiological changes Time 0 (H0) 
to 6 hours (H6) 
   
  Respiratory rate reduction  6 bpm 8 bpm 0.001 
  SBP reduction 35 mm Hg 19 mm Hg 0.52 
  DBP reduction 25 mm Hg 16 mm Hg 0.035 
  Heart rate reduction 20 beats/min 6 beats/min 0.023 
 Successful treatment within first 48 
hours = absence of death, 
intubation criteria & persistence of 
either all inclusion criteria or 
circulatory failure 2-48 hours 
63 (63%) 84 (79%) OR 2.1; 95% CI 1.2 to 4.0 
 Persistence of inclusion criteria 
after 2 hours 
23 (26%) 12 (12%) OR 2.5; 95% CI 1.2 to 5.5 
 Met intubation criteria within 48 
hours 
13 (14%) 4 (4%) OR 3.9, 95% CI 1.2, 12.5 
 Intubated within 48 hours 6 (6%) 5 (5%) OR 3.9; 95% CI 1.2 to 12.5 
 Mortality n (%) 5 (5%) 4 (4%) OR 1.4; 95% CI 0. 4 to 5.2 
 Median ICU LOS 2 days 2 days 0.67 
Frontin et al. (2011)36 
Non-CPAP = 62 
CPAP = 60 
Treatment success, i.e. respiratory 
rate < 25 bpm and oxygen 
saturation > 90% at the end of 1-
hour study 
22 (35.5%) 19 (31.7%) 0.65 
 Physiology changes at 1 hour    
  Mean respiratory rate (bpm) 8.5 4.9  
  Mean SpO2    
  Mean heart rate    
  Mean systolic pressure    
  Mean diastolic pressure    
 Prehospital intubation 1 (2%) 0  
 Intubation within 1 month 3 (5%) 2 (3%) 0.52 
 Died within 30 days 7 (11%) 6 (10%) 0.52 
 Median ICU LOS 8.2 hours 8 hours 0.27 
 Median hospital LOS 6 days 6 days 0.50 
 Dyspnoea score 4.8 5.3 0.47 
Hubble et al. (2006)38 Pre-hospital time 30 32  
Non-CPAP=95 Physiology changes    
CPAP=120  Improvement in respiratory 
rate 
-1.81 -4.55 0.001 
  Improvement in pulse rate 0.82 -4.77 0.013 




 Pre-hospital intubation 7 (7%) 5 (4%) 0.48 
 Intubation anytime 25% 9% OR 4.0; 95% CI 1.6 to 9.9 
 In-hospital mortality 23% 5% OR 7.5; 95% CI 2.0 to 28.5 
 Hospital LOS 8 days 6 days 0.76 
Thompson et al.14 Scene time 21 minutes 22 minutes  
Non-CPAP=35 
CPAP=34 
Prehospital intubation 9 








7 (20%) Unadjusted OR 0.25; 95% CI 
0.09 to 0.73; adjusted OR 
0.16; 95% CI 0.04 to 0.7 
 Mortality 12 (35%) 5 (14%)  Unadjusted OR 0.3; 95% CI 
0.09 to 0.99 
 Number of critical care admissions 16 (47) 13 (37)  
 Median critical care LOS 3 days 6.5 days  
 Hospital LOS 9 days 7 days  
*Pre-hospital time = arrival at scene to arrival at emergency department 
bpm breaths per minute 
CI Confidence Interval 
DBP Diastolic Blood Pressure 
LOS Length of Stay 
OR Odds Ratios 
SBP Systolic Blood Pressure 
SaO2 Arterial Oxygen Saturation 
SpO2 Peripheral Oxygen Saturation 
 
 
